{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:16:24Z","timestamp":1793070984695,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"am","delay-in-days":477,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.berh.2022.101768","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T07:51:29Z","timestamp":1657007489000},"page":"101768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Calcinosis in dermatomyositis: Origins and possible therapeutic avenues"],"prefix":"10.1016","volume":"36","author":[{"given":"Srijana","family":"Davuluri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargavi","family":"Duvvuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Faghihi-Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0482-50042012000400007","article-title":"High frequency of calcinosis in juvenile dermatomyositis: a risk factor study","volume":"52","author":"Clemente","year":"2012","journal-title":"Rev Bras Reumatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1529-8019.2012.01492.x","article-title":"Calcinosis cutis in autoimmune connective tissue diseases","volume":"25","author":"Gutierrez","year":"2012","journal-title":"Dermatol Ther"},{"issue":"5 Pt 1","key":"10.1016\/j.berh.2022.101768_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0190-9622(95)91803-5","article-title":"Calcifying disorders of the skin","volume":"33","author":"Walsh","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.berh.2022.101768_bib5","first-page":"979","article-title":"Dermatomyositis and focal scleroderma","volume":"10","author":"Cook","year":"1963","journal-title":"Pediatr Clin"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","article-title":"Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis","volume":"150","author":"Valenzuela","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2214\/ajr.142.2.397","article-title":"Patterns of calcification in childhood dermatomyositis","volume":"142","author":"Blane","year":"1984","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.berh.2022.101768_bib9","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1007\/s10067-021-05696-6","article-title":"A\u00a0narrative review of imaging in calcinosis associated with systemic sclerosis","volume":"40","author":"Mar","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-017-0199-4","article-title":"Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA)","volume":"15","author":"Orandi","year":"2017","journal-title":"Pediatr Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/8756-3282(95)00076-P","article-title":"The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix","volume":"16","author":"Landis","year":"1995","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib12","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/ar2841","article-title":"Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies","volume":"11","author":"Eidelman","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.berh.2022.101768_bib13","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/art.22158","article-title":"Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation","volume":"54","author":"Pachman","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.24391","article-title":"Juvenile dermatomyositis calcifications selectively displayed markers of bone formation","volume":"61","author":"Urganus","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/rheumatology\/ken136","article-title":"Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis","volume":"47","author":"Marhaug","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102533","article-title":"Calcinosis biomarkers in adult and juvenile dermatomyositis","volume":"19","author":"Chung","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib17","first-page":"E45","article-title":"Macrophages highly express carbonic anhydrase 2 and play a significant role in demineralization of the ectopic calcification","volume":"63","author":"Barinda","year":"2017","journal-title":"Kobe J Med Sci"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib18","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/art.20254","article-title":"Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG","volume":"50","author":"L\u00f6vgren","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clim.2007.06.011","article-title":"Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease","volume":"125","author":"Zhao","year":"2007","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.41078","article-title":"Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis","volume":"72","author":"Duvvuri","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","article-title":"Duration of illness is an important variable for untreated children with juvenile dermatomyositis","volume":"148","author":"Pachman","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00223-009-9271-5","article-title":"Characterization of dystrophic calcification induced in mice by cardiotoxin","volume":"85","author":"Zhao","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"10.1016\/j.berh.2022.101768_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11926-996-0031-5","article-title":"Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis","volume":"8","author":"Pachman","year":"2006","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.semarthrit.2020.06.007","article-title":"Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis","volume":"50","author":"Valenzuela","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semarthrit.2016.05.008","article-title":"Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a Scleroderma Clinical Trials Consortium study","volume":"46","author":"Valenzuela","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.2010.134304","article-title":"Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2022.101768_bib28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/acr.24327","article-title":"Ultrasound detection of calcinosis and association with ulnar artery occlusion in patients with systemic sclerosis","volume":"73","author":"Fairchild","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.kint.2016.05.020","article-title":"Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification","volume":"90","author":"Mokas","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40478-016-0308-5","article-title":"Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis","volume":"4","author":"Preu\u00dfe","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"10.1016\/j.berh.2022.101768_bib31","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","article-title":"TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications","volume":"43","author":"Pachman","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2022.101768_bib32","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.24039","article-title":"Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis","volume":"58","author":"Mamyrova","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib33","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20210008","article-title":"Mitochondrial calcification","volume":"3","author":"Duvvuri","year":"2021","journal-title":"Immunometabolism"},{"key":"10.1016\/j.berh.2022.101768_bib34","series-title":"Mitochondrial ROS as a regulator of calcinosis in juvenile dermatomyositis","author":"Duvvuri","year":"2020"},{"key":"10.1016\/j.berh.2022.101768_bib35","series-title":"Mitochondrial calcification-induced inflammation in human skeletal muscle and immune cells. American college of rheumatology convergence","author":"Duvvuri","year":"2021"},{"key":"10.1016\/j.berh.2022.101768_bib36","series-title":"Mitochondrial contribution to juvenile dermatomyositis pathogenesis","author":"Duvvuri","year":"2019"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib38","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1084\/jem.20161512","article-title":"TLR7\/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA","volume":"214","author":"Lood","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib40","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1038\/s41598-017-03086-0","article-title":"The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation","volume":"7","author":"Lebre","year":"2017","journal-title":"Sci Rep"},{"issue":"36","key":"10.1016\/j.berh.2022.101768_bib41","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1073\/pnas.1111101108","article-title":"NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy","volume":"108","author":"Jin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2990.1997.tb01195.x","article-title":"Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes","volume":"23","author":"Authier","year":"1997","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"10.1016\/j.berh.2022.101768_bib43","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/rheumatology\/key222","article-title":"Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment","volume":"57","author":"Helmers","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-2828(78)90042-1","article-title":"Mitochondrial calcium overloading in cardiomyopathic hamsters","volume":"10","author":"Wrogemann","year":"1978","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib45","doi-asserted-by":"crossref","first-page":"B12","DOI":"10.1016\/0002-9149(94)90259-3","article-title":"Molecular studies of the calcium antagonist binding site on calcium channels","volume":"73","author":"Schwartz","year":"1994","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.880050114","article-title":"The effects of diltiazem in dystrophic hamsters","volume":"5","author":"Bhattacharya","year":"1982","journal-title":"Muscle Nerve: Official Journal of the American Association of Electrodiagnostic Medicine"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00131402-200106000-00005","article-title":"Diltiazem in the treatment of calcinosis in juvenile dermatomyositis","volume":"2","author":"Bertorini","year":"2001","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/rheumatology\/39.3.333","article-title":"Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy","volume":"39","author":"Vinen","year":"2000","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib49","first-page":"102","article-title":"Regression of cutis calcinosis with diltiazem in adult dermatomyositis","volume":"15","author":"Abdallah-Lotf","year":"2005","journal-title":"Eur J Dermatol: EJD."},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","article-title":"Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009","volume":"148","author":"Balin","year":"2012","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.berh.2022.101768_bib51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1310\/hpj5011-975","article-title":"Sodium thiosulfate: calciphylaxis","volume":"50","author":"Generali","year":"2015","journal-title":"Hosp Pharm"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jdcr.2019.12.017","article-title":"Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate","volume":"6","author":"Abbott","year":"2020","journal-title":"JAAD Case Reports"},{"issue":"9","key":"10.1016\/j.berh.2022.101768_bib53","article-title":"Dystrophic calcinosis cutis in autosomal recessive dystrophic epidermolysis bullosa","volume":"12","author":"Bhari","year":"2019","journal-title":"BMJ Case Reports CP"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4274\/jcrpe.galenos.2021.2020.0269","article-title":"The successful treatment of deep soft-tissue calcifications with topical sodium thiosulphate and acetazolamide in a boy with hyperphosphatemic familial tumoral calcinosis due to a novel mutation in FGF23","volume":"14","author":"Doneray","year":"2021","journal-title":"Journal of Clinical Research in Pediatric Endocrinology"},{"issue":"10","key":"10.1016\/j.berh.2022.101768_bib55","first-page":"1181","article-title":"Topical sodium thiosulfate: a reliable treatment for digital calcinosis cutis\u2013a case series with six patients","volume":"18","author":"von Hodenberg","year":"2020","journal-title":"JDDG J der Deutschen Dermatol Gesellschaft"},{"issue":"11","key":"10.1016\/j.berh.2022.101768_bib56","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jdcr.2019.08.011","article-title":"Successful treatment of calcinosis cutis of fingertip in the setting of CREST syndrome with topical 20% sodium thiosulfate","volume":"5","author":"Tajalli","year":"2019","journal-title":"JAAD Case Reports"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib57","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1111\/pde.13868","article-title":"Linear amyopathic dermatomyositis with calcinosis cutis responsive to topical sodium thiosulfate","volume":"36","author":"Topham","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib58","first-page":"1092","article-title":"Treatment of calcinosis associated with adult and juvenile dermatomyositis using topical sodium thiosulfate via fractionated CO2 laser treatment","volume":"37","author":"Eleryan","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjd.14412","article-title":"Topical sodium metabisulfite for the treatment of calcinosis cutis: a promising new therapy","volume":"175","author":"Del Barrio-D\u00edaz","year":"2016","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib60","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1111\/ced.13782","article-title":"Topical sodium thiosulfate for calcinosis cutis associated with autoimmune connective tissue diseases: the Mayo Clinic experience, 2012\u20132017","volume":"44","author":"Ma","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.berh.2022.101768_bib61","first-page":"1","article-title":"Local, non-systemic, and minimally invasive therapies for calcinosis cutis: a systematic review","author":"Nowaczyk","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.berh.2022.101768_bib62","series-title":"Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: two cases. Seminars in arthritis and rheumatism","author":"Goossens","year":"2017"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2340\/00015555-2206","article-title":"Treatment of skin calcifications with intra-lesional injection of sodium thiosulphate: a case series","volume":"96","author":"Baumgartner-Nielsen","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib64","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s10067-020-05523-4","article-title":"Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review","volume":"40","author":"L\u00f3pez-Sundh","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib65","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jdin.2020.07.002","article-title":"Efficacy of intralesional sodium thiosulfate for the treatment of dystrophic calcinosis cutis: a double-blind, placebo-controlled pilot study","volume":"1","author":"Winter","year":"2020","journal-title":"JAAD international"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib66","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.09880912","article-title":"Sodium thiosulfate therapy for calcific uremic arteriolopathy","volume":"8","author":"Nigwekar","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbspin.2015.03.007","article-title":"Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis","volume":"83","author":"Malbos","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib68","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.12788\/cutis.0071","article-title":"Dystrophic calcinosis cutis: treatment with intravenous sodium thiosulfate","volume":"106","author":"Badawi","year":"2020","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib69","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jbspin.2016.10.009","article-title":"Intravenous sodium thiosulfate for treating tumoral calcinosis associated with systemic disorders: report of four cases","volume":"84","author":"Mageau","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib70","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/bjd.15783","article-title":"Lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutis","volume":"178","author":"Song","year":"2018","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib71","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10611869409015910","article-title":"Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in\u00a0vitro","volume":"2","author":"M\u00f6nkk\u00f6nen","year":"1994","journal-title":"J\u00a0Drug Target"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/14397595.2014.988197","article-title":"Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis","volume":"25","author":"Tayfur","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib73","first-page":"135","article-title":"Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis","volume":"28","author":"Puche","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jbspin.2009.04.011","article-title":"Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate","volume":"77","author":"Slimani","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.berh.2022.101768_bib75","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","article-title":"Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study","volume":"43","author":"Bianchi","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib76","first-page":"1129","article-title":"Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications","volume":"28","author":"Harel","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"5794","key":"10.1016\/j.berh.2022.101768_bib77","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.1.5794.216","article-title":"Treatment of calcinosis circumscripta with probenecid","volume":"1","author":"Dent","year":"1972","journal-title":"Br Med J"},{"issue":"5816","key":"10.1016\/j.berh.2022.101768_bib78","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/bmj.2.5816.768-b","article-title":"Probenecid in calcification of the hands","volume":"2","author":"MacKie","year":"1972","journal-title":"Br Med J"},{"issue":"12","key":"10.1016\/j.berh.2022.101768_bib79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5694\/j.1326-5377.1976.tb130327.x","article-title":"Treatment of calcinosis circumscripta and Raynaud's phenomenon","volume":"2","author":"Meyers","year":"1976","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/03009748109095279","article-title":"Calcinosis in dermatomyositis treated with probenecid","volume":"10","author":"Skuterud","year":"1981","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2022.101768_bib81","first-page":"3536","article-title":"Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy","volume":"82","author":"Eddy","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.berh.2022.101768_bib82","first-page":"1691","article-title":"Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis","volume":"33","author":"Nakamura","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib83","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13075-020-02164-5","article-title":"Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients","volume":"22","author":"Campanilho-Marques","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib85","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/rheumatology\/ket365","article-title":"Successful treatment of calcinosis with infliximab in a patient with systemic sclerosis\/myositis overlap syndrome","volume":"53","author":"Tosounidou","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib86","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/ced.14325","article-title":"Successful treatment of dermatomyositis and associated calcinosis with adalimumab","volume":"45","author":"Xie","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib87","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3899\/jrheum.101321","article-title":"Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry","volume":"38","author":"Bader-Meunier","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/rheumatology\/kew396","article-title":"Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab","volume":"56","author":"Aggarwal","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.berh.2022.101768_bib89","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1093\/rheumatology\/keab421","article-title":"Calcinosis in refractory dermatomyositis improves with tofacitinib monotherapy: a case series","volume":"60","author":"Shneyderman","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2022.101768_bib90","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaut.2019.03.003","article-title":"Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - a report of two cases","volume":"100","author":"Wendel","year":"2019","journal-title":"J\u00a0Autoimmun"},{"issue":"12","key":"10.1016\/j.berh.2022.101768_bib91","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1093\/rheumatology\/keaa360","article-title":"A\u00a0striking treatment option for recalcitrant calcinosis in juvenile dermatomyositis: tofacitinib citrate","volume":"59","author":"S\u00f6zeri","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib92","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1093\/brain\/awz005","article-title":"Janus kinase 1\/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis","volume":"142","author":"Papadopoulou","year":"2019","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.berh.2022.101768_bib93","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/brain\/awz293","article-title":"Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib","volume":"142","author":"Sabbagh","year":"2019","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199201093260206","article-title":"Manipulating the immune system with immune globulin","volume":"326","author":"Dwyer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.berh.2022.101768_bib96","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A\u00a0controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2022.101768_bib97","series-title":"Efficacy and safety of IVIg (octagam 10%) in patients with active dermatomyositis. Results of a randomized, double-blind, placebo-controlled phase III trial (ProDERM study)","author":"Aggarwal","year":"2020"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib98","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jbspin.2012.07.001","article-title":"Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy","volume":"80","author":"Touimy","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.berh.2022.101768_bib99","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jaad.2008.09.051","article-title":"Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin","volume":"60","author":"Pe\u00f1ate","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.berh.2022.101768_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006629","article-title":"Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin","volume":"2012","author":"Shahani","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib101","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaad.2015.03.047","article-title":"Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis","volume":"73","author":"Galimberti","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib102","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1023\/A:1011990129437","article-title":"Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders","volume":"15","author":"Cohen","year":"1998","journal-title":"Pharm Res (N Y)"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib103","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.62.3.267","article-title":"Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline","volume":"62","author":"Robertson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2022.101768_bib104","first-page":"2019","article-title":"Minocycline for refractory calcinosis in systemic sclerosis: a single-centre observational cohort study","author":"Carmen Fonseca","year":"2019","journal-title":"American College of Rheumatology"},{"issue":"8","key":"10.1016\/j.berh.2022.101768_bib105","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/kep151","article-title":"Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis","volume":"48","author":"Davies","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2022.101768_bib106","series-title":"A\u00a0pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis","author":"Chung","year":"2021"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-291X(76)90714-2","article-title":"The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification","volume":"73","author":"Lian","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.berh.2022.101768_bib108","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780250910","article-title":"GAMMA-carboxyglutamate excretion and calcinosis in juvenile dermatomyositis","volume":"25","author":"Lian","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib109","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0002-9343(87)90499-2","article-title":"Treatment of calcinosis universalis with low-dose warfarin","volume":"83","author":"Berger","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib110a","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0002-9343(88)90128-3","article-title":"Failure of warfarin in treatment of calcinosis universalis","volume":"84","author":"Lassoued","year":"1988","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.berh.2022.101768_bib110b","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/ard.2003.014431","article-title":"Low dose warfarin treatment for calcinosis in patients with systemic sclerosis","volume":"63","author":"Cukierman","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2022.101768_bib111","first-page":"1233","article-title":"The effects of warfarin on calcinosis in a patient with systemic sclerosis","volume":"20","author":"Yoshida","year":"1993","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2022.101768_bib112","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/01.ATV.0000173313.46222.43","article-title":"Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification","volume":"25","author":"Schurgers","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib113","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1073\/pnas.81.2.371","article-title":"Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography","volume":"81","author":"Urist","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.berh.2022.101768_bib114","doi-asserted-by":"crossref","first-page":"14044","DOI":"10.1074\/jbc.M008103200","article-title":"Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1\/2 cells","volume":"276","author":"Bostr\u00f6m","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.ATV.20.2.317","article-title":"Warfarin-induced artery calcification is accelerated by growth and vitamin D","volume":"20","author":"Price","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib116","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002665","article-title":"Increased peripheral arterial calcification in patients receiving warfarin","volume":"5","author":"Han","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.berh.2022.101768_bib117","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaad.2010.12.035","article-title":"Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy","volume":"66","author":"Sultan-Bichat","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib118","first-page":"177","article-title":"Safety and efficacy of extracorporeal shock wave therapy (ESWT) in calcinosis cutis associated with systemic sclerosis","volume":"34","author":"Blumhardt","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib119","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10067-004-1023-3","article-title":"Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis-old method, new discovery","volume":"24","author":"Chan","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00401-017-1731-9","article-title":"IFN-\u03b2-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis","volume":"134","author":"Meyer","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib121","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000387","article-title":"Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice","volume":"7","author":"Fortner","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib122","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41927-021-00176-5","article-title":"Resolution of calcinosis using bisphosphonates in overlap syndrome - a case report","volume":"5","author":"Platter","year":"2021","journal-title":"BMC Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2022.101768_bib123","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00198-020-05391-3","article-title":"Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study","volume":"31","author":"Chen","year":"2020","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.berh.2022.101768_bib124","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/bjd.14550","article-title":"Worsening of calcinosis cutis with teriparatide treatment in two osteoporotic patients","volume":"175","author":"Echeverri","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101768_bib125","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00198-017-4330-7","article-title":"Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide","volume":"29","author":"Htet","year":"2018","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.berh.2022.101768_bib126","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.berh.2022.101768_bib127","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02547227","article-title":"The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals","volume":"11","author":"Jung","year":"1973","journal-title":"Calcif Tissue Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101768_bib128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.berh.2022.101768_bib129","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/art.40149","article-title":"American college of rheumatology\/American association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:21:17Z","timestamp":1761499277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694222000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1521694222000274"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2022.101768","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcinosis in dermatomyositis: Origins and possible therapeutic avenues","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2022.101768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101768"}}